The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 13.13
Myeloid Leukemia
SEER Incidencea Rates, Age-Adjusted and Age-Specific Rates, by Race and Sex
Acute Myeloid Leukemia, Age-Adjusted SEER Incidence Rates, 2012-2016
| Age at Diagnosis | All Races | Whites | Blacks | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Both Sexes | Males | Females | Both Sexes | Males | Females | Both Sexes | Males | Females | |
| All ages | 4.3 | 5.2 | 3.5 | 4.4 | 5.4 | 3.6 | 3.7 | 4.4 | 3.3 |
| Under 65 | 2.0 | 2.1 | 1.9 | 2.0 | 2.1 | 1.9 | 2.0 | 2.0 | 2.0 |
| 65 and over | 20.1 | 26.9 | 15.2 | 21.3 | 28.4 | 16.0 | 15.5 | 21.0 | 12.3 |
| All ages (WHO world std)b | 3.2 | 3.8 | 2.8 | 3.3 | 4.0 | 2.8 | 2.9 | 3.3 | 2.7 |
Acute Myeloid Leukemia, Age-Specific SEER Incidence Rates, 2012-2016
| Age at Diagnosis | All Races | Whites | Blacks | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Both Sexes | Males | Females | Both Sexes | Males | Females | Both Sexes | Males | Females | |
| <1 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 | 1.5 | - | - | - |
| 1-4 | 1.0 | 1.0 | 1.0 | 0.9 | 0.9 | 0.9 | 1.1 | 1.0 | 1.1 |
| 5-9 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | - | - |
| 10-14 | 0.7 | 0.8 | 0.6 | 0.7 | 0.8 | 0.6 | 0.9 | 0.9 | 0.8 |
| 15-19 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 0.9 | 0.8 | 0.7 | 0.8 |
| 20-24 | 1.1 | 1.0 | 1.2 | 1.1 | 1.0 | 1.2 | 1.2 | 1.1 | 1.3 |
| 25-29 | 1.2 | 1.1 | 1.2 | 1.1 | 1.1 | 1.2 | 1.1 | 1.0 | 1.2 |
| 30-34 | 1.4 | 1.5 | 1.4 | 1.4 | 1.5 | 1.4 | 1.7 | 1.5 | 1.9 |
| 35-39 | 1.6 | 1.6 | 1.6 | 1.5 | 1.6 | 1.5 | 1.8 | 1.6 | 2.0 |
| 40-44 | 2.1 | 2.2 | 2.1 | 2.2 | 2.2 | 2.2 | 2.2 | 2.1 | 2.2 |
| 45-49 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.8 | 2.7 | 2.9 |
| 50-54 | 3.5 | 3.8 | 3.2 | 3.6 | 4.0 | 3.3 | 3.3 | 3.2 | 3.3 |
| 55-59 | 4.9 | 5.6 | 4.3 | 4.9 | 5.6 | 4.3 | 4.9 | 5.7 | 4.3 |
| 60-64 | 7.8 | 9.1 | 6.7 | 8.2 | 9.7 | 6.8 | 7.0 | 7.5 | 6.6 |
| 65-69 | 12.1 | 15.2 | 9.4 | 12.9 | 16.3 | 9.8 | 10.0 | 11.8 | 8.6 |
| 70-74 | 18.3 | 23.6 | 13.9 | 19.2 | 24.7 | 14.5 | 15.1 | 18.9 | 12.5 |
| 75-79 | 23.3 | 31.0 | 17.4 | 24.8 | 32.6 | 18.6 | 18.5 | 25.6 | 14.0 |
| 80-84 | 28.6 | 39.3 | 21.2 | 30.2 | 41.3 | 22.3 | 20.7 | 31.4 | 14.8 |
| 85+ | 26.3 | 38.0 | 20.3 | 27.7 | 40.3 | 21.2 | 17.4 | 25.4 | 14.1 |
Chronic Myeloid Leukemia, Age-Adjusted SEER Incidence Rates, 2012-2016
| Age at Diagnosis | All Races | Whites | Blacks | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Both Sexes | Males | Females | Both Sexes | Males | Females | Both Sexes | Males | Females | |
| All ages | 1.9 | 2.4 | 1.4 | 1.9 | 2.5 | 1.5 | 1.8 | 2.2 | 1.5 |
| Under 65 | 1.1 | 1.3 | 0.9 | 1.1 | 1.2 | 0.9 | 1.1 | 1.3 | 1.0 |
| 65 and over | 7.6 | 10.6 | 5.5 | 8.0 | 11.1 | 5.7 | 6.2 | 8.2 | 4.9 |
| All ages (WHO world std)b | 1.5 | 1.9 | 1.1 | 1.5 | 1.9 | 1.2 | 1.4 | 1.7 | 1.2 |
Chronic Myeloid Leukemia, Age-Specific SEER Incidence Rates, 2012-2016
| Age at Diagnosis | All Races | Whites | Blacks | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Both Sexes | Males | Females | Both Sexes | Males | Females | Both Sexes | Males | Females | |
| <1 | 0.5 | 0.5 | - | 0.4 | - | - | - | - | - |
| 1-4 | 0.1 | - | - | 0.1 | - | - | - | - | - |
| 5-9 | 0.1 | - | 0.1 | 0.1 | - | - | - | - | - |
| 10-14 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | - | - | - |
| 15-19 | 0.3 | 0.3 | 0.2 | 0.2 | 0.3 | 0.2 | 0.3 | - | - |
| 20-24 | 0.5 | 0.6 | 0.4 | 0.5 | 0.6 | 0.4 | 0.4 | - | - |
| 25-29 | 0.7 | 0.9 | 0.6 | 0.7 | 0.8 | 0.6 | 0.7 | 1.0 | - |
| 30-34 | 1.0 | 1.2 | 0.8 | 1.1 | 1.2 | 0.9 | 0.8 | 0.9 | 0.8 |
| 35-39 | 1.1 | 1.3 | 0.9 | 1.1 | 1.3 | 1.0 | 1.2 | 1.3 | 1.0 |
| 40-44 | 1.4 | 1.8 | 1.1 | 1.4 | 1.8 | 1.1 | 1.6 | 2.2 | 1.0 |
| 45-49 | 1.8 | 2.1 | 1.5 | 1.7 | 2.0 | 1.4 | 2.5 | 2.8 | 2.3 |
| 50-54 | 2.2 | 2.6 | 1.7 | 2.1 | 2.6 | 1.7 | 2.3 | 2.5 | 2.0 |
| 55-59 | 2.5 | 2.9 | 2.2 | 2.6 | 2.9 | 2.3 | 2.5 | 2.8 | 2.2 |
| 60-64 | 3.5 | 4.3 | 2.7 | 3.5 | 4.4 | 2.7 | 3.4 | 4.1 | 2.9 |
| 65-69 | 4.9 | 6.7 | 3.4 | 5.0 | 6.8 | 3.3 | 5.5 | 6.8 | 4.5 |
| 70-74 | 6.5 | 8.5 | 4.8 | 6.8 | 8.9 | 5.1 | 4.9 | 6.6 | 3.6 |
| 75-79 | 9.1 | 12.4 | 6.5 | 9.7 | 13.2 | 6.9 | 6.9 | 9.8 | 5.0 |
| 80-84 | 10.5 | 14.7 | 7.5 | 11.2 | 15.6 | 8.0 | 7.6 | 9.2 | 6.7 |
| 85+ | 10.2 | 15.5 | 7.5 | 10.7 | 16.4 | 7.6 | 7.5 | 10.9 | 6.0 |
Footnotes:
a SEER 21 areas. Rates are per 100,000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130), unless noted.
b Rates are per 100,000 and are age-adjusted to the world (WHO 2000-2025) standard million.
- Statistic not shown. Rate based on less than 16 cases for the time interval.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.